Industry: Pharmaceuticals

Teva to be investigated by FTC, ramping up scrutiny of Orange Book listings

Antitrust challenges against pharma patent strategies continue to escalate

02 July 2024

Federal Circuit’s latest skinny label decision is another headache for generics

Appellate court hands down guidance on induced infringement cases

28 June 2024

UPC’s first ever pharma preliminary injunction decisions add to patentees’ losing streak

Alexion Pharmaceuticals denied PI requests against biosimilar eculizumab producers Amgen and Samsung Bioepis

27 June 2024

How new technologies are reshaping IP and deal terms in life sciences transactions

Each speciality comes with its own challenges and risks which shape how deals are negotiated and structured – and there is no ‘one-size fits all’ approach

26 June 2024

South Africa: Winning strategies to keep pace with evolving pharma sector

Featured in The Guide to Life Sciences: Key issues for senior life sciences executives 2024

The South African pharmaceutical industry has grown substantially in recent years, while patent legislation has undergone significant divergence. Effective enforcement, prosecution and launch-to-market strategies require a keen understanding of the country’s IP and regulatory frameworks.

24 June 2024

Three crucial lessons to navigate IP and regulatory devils in medical innovation

Advice for biotech-pharma innovators to manage IP strategy while taking the risky gamble of introducing new drugs or medical devices to market

14 June 2024

Software assets dominate market: patent transactions in Q1 2024

AST reports that deal numbers were influenced by economic conditions, trends in litigation funding, licensing cycles, and operating companies selling non-core assets

04 June 2024

Bayer suffers big blow at UK Court of Appeal, clearing path for generic Xarelto launches

The German company remains involved in more than 70 proceedings across 20-plus European countries

28 May 2024

The UPC may be reaching a turning point for pharma patent cases

Saturday Opinion: Use of the pan-European court by drug patentees picks up pace as Sanofi takes aim at four generics

25 May 2024

Pfizer unit awarded $108 million for AstraZeneca infringement by Delaware jury

But big money pharma patent damages have a habit of being overturned

21 May 2024